Company · CIK 0001349426
Omrix Biopharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AOmrix Biopharmaceuticals, Inc.0001193125-09-029034 · 81.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001299933-08-004552 · 28.7 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950123-08-009317 · 254.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001299933-08-003852 · 70.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001299933-08-003849 · 56.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001299933-08-002570 · 16.8 KBSEC(opens sec.gov)
- SC 13G/AOmrix Biopharmaceuticals, Inc.0001104659-08-023427 · 70.1 KBSEC(opens sec.gov)
- SC 13G/AOmrix Biopharmaceuticals, Inc.0000315066-08-002342 · 8.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001299933-08-000615 · 28.6 KBSEC(opens sec.gov)
- 4Insider trades0001209191-08-002277 · 6.6 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
630 FIFTH AVENUE, 22ND FLOOR
NEW YORK, NY, 10111
mailing
630 FIFTH AVENUE, 22ND FLOOR
NEW YORK, NY, 10111
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies